<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> has several levels of abnormalities </plain></SENT>
<SENT sid="1" pm="."><plain>To define the primary abnormalities of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, we conducted an autopsy study of 186 consecutive patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> to determine correlations among the <z:chebi fb="0" ids="15693">aldose</z:chebi> reductase gene, renal histopathologies, extracellular matrix, glomerular function, and clinical characteristics </plain></SENT>
<SENT sid="2" pm="."><plain>Compared with cases of near-<z:mpath ids='MPATH_458'>normal</z:mpath> renal structure (n = 51) and atypical diabetic <z:hpo ids='HP_0100820'>glomerulopathy</z:hpo> (n = 75), patients with classic diabetic <z:hpo ids='HP_0100820'>glomerulopathy</z:hpo> (n = 60) had advanced <z:e sem="disease" ids="C0268731" disease_type="Disease or Syndrome" abbrv="">glomerular disease</z:e>, as reflected by elevated plasma <z:chebi fb="0" ids="16737">creatinine</z:chebi> levels (133.2 +/- 59.8 vs. 166.0 +/- 65.7 vs. 243.8 +/- 82.6 micromol/l; P &lt; 0.001), glomerular matrix fractions (20.8 +/- 6.7 vs. 33.5 +/- 16.8 vs. 39.2 +/- 14.3%; P &lt; 0.001), and risk of <z:hpo ids='HP_0000083'>renal failure</z:hpo> (odds ratio [OR] 1 vs. 3.5 vs. 21.4; P &lt; 0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>Compared with noncarriers of the <z:chebi fb="0" ids="15693">aldose</z:chebi> reductase z-2 allele (n = 92) and z-2 heterozygotes (n = 77), z-2 homozygotes (n = 17) had elevated plasma <z:chebi fb="0" ids="16737">creatinine</z:chebi> (164.1 +/- 73.7 vs. 190.6 +/- 60.9 vs. 241.1 +/- 86.2 micromol/l; P &lt; 0.001) and an increased risk of classic diabetic <z:hpo ids='HP_0100820'>glomerulopathy</z:hpo> (OR 1 vs. 0.9 vs. 3.3; P = 0.026) </plain></SENT>
<SENT sid="4" pm="."><plain>Overexpression of transforming growth factor-beta1, mesangial cell <z:mpath ids='MPATH_85'>transdifferentiation</z:mpath> by expression of alpha-smooth muscle actin, and aberrant deposition of collagen type IV, fibronectin, and laminin were found in classic diabetic <z:hpo ids='HP_0100820'>glomerulopathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>These data suggest genetic, biochemical, pathophysiological, and clinical correlations among the <z:chebi fb="0" ids="15693">aldose</z:chebi> reductase gene, extracellular matrix, classic diabetic <z:hpo ids='HP_0100820'>glomerulopathy</z:hpo>, and <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Gene mutation, cellular <z:mpath ids='MPATH_85'>transdifferentiation</z:mpath>, growth factor upregulation, extracellular matrix expansion, and glomerular filtration impairment are the primary abnormalities in type 2 diabetic patients with <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
</text></document>